Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ACHILLION PHARMACEUTICALS INC (ACHN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-19Jun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18Mar-31-18Dec-31-17
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenue          
Operating expenses          
Research and development  56.654.449.548.852.254.962.263.6
General and administrative  23.722.024.425.328.028.426.326.0
Restructuring charges (Note 4)    0.8 1.91.81.8 
    Total operating expenses  80.977.274.775.982.185.290.289.6
    Loss from operations  -80.9-77.2-74.7-75.9-82.1-85.2-90.2-89.6
   
Other income (expense)          
Interest income  6.46.46.15.75.34.94.64.4
Interest expense  0.00.00.00.00.00.00.0-0.1
    Net loss  -74.6-70.9-68.6-70.3-76.9-80.3-85.7-85.2
   
Basic and diluted net loss per share (Note 5)  ($0.54)($0.52)($0.50)($0.51)($0.56)($0.58)($0.62)($0.62)
Total comprehensive loss (Note 9)  -74.1-70.2-67.8-70.1-77.0-80.6-86.4-85.8
   
Weighted average number of shares used in computing basic and diluted net loss per share  138.9138.6138.5138.4138.1137.7137.3137.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy